Opko says deal will help it concentrate on drug and diagnostic development for eye diseases. Opko Health is getting $17.5 million in cash for selling its ophthalmic instrumentation business to Optos.

The purpose of this report is to demonstrate that a non-contact ultra-widefield dual wavelength laser camera (Optos) is able to capture high-quality images in retinopathy of prematurity (ROP). We ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Opko Health signed a deal to sell its ophthalmic ...

Shares in Optos gain 4.2 percent after the firm acquires the distribution rights to three ophthalmic devices from Accutome Inc., prompting Singer Capital to up its rating for the stock to "buy" from ...

(MENAFN- EIN Presswire) EINPresswire/ -- Future Market Insights (FMI), a leading market intelligence and consulting firm, today released its comprehensive report on the ophthalmic diagnostic equipment ...